Table 3.

Percent of patients with continuing opioid fills occurring in monthly time windows after hysterectomy.

Perioperative Fill	All Hysterectomy	Abdominal	Laparoscopic	Vaginal
Total Number of Patients	393,096	133,510	192,017	67,569
% with Perioperative Fill	331,322 (84.3%)	112,408 (84.2%)	163,724 (85.3%)	55,190 (81.7%)
Postoperative Period	Percent (95% CI)*
Perioperative Fill	100 (100–100)	100 (100–100)	100 (100–100)	100 (100–100)
1 – 30 Follow-up	14.2 (14.1–14.3)	20.4 (20.1–20.6)	10.8 (10.6–11.0)	11.6 (11.4–11.9)
31 – 60 Follow-up	1.40 (1.36–1.44)	2.11 (2.02–2.19)	1.00 (0.95–1.05)	1.15 (1.05–1.24)
61 – 90 Follow-up	0.34 (0.31–0.36)	0.48 (0.43–0.52)	0.27 (0.24–0.29)	0.25 (0.20–0.29)
91 – 120 Follow-up	0.15 (0.13–0.16)	0.21 (0.18–0.24)	0.11 (0.10–0.13)	0.11 (0.08–0.14)
121 – 150 Follow-up	0.09 (0.08–0.10)	0.12 (0.10–0.14)	0.07 (0.06–0.09)	0.07 (0.05–0.10)
151 – 180 Follow-up	0.06 (0.05–0.07)	0.09 (0.07–0.11)	0.05 (0.04–0.06)	0.06 (0.03–0.08)
181 – 210 Follow-up	0.05 (0.04–0.06)	0.07 (0.06–0.09)	0.04 (0.03–0.05)	0.05 (0.02–0.07)
211 – 240 Follow-up	0.04 (0.03–0.05)	0.06 (0.04–0.08)	0.03 (0.02–0.04)	0.04 (0.02–0.06)
241 – 270 Follow-up	0.04 (0.03–0.04)	0.05 (0.03–0.07)	0.03 (0.02–0.04)	0.03 (0.01–0.05)
271 – 300 Follow-up	0.03 (0.02–0.04)	0.04 (0.03–0.06)	0.02 (0.01–0.03)	0.03 (0.01–0.05)
301– 330 Follow-up	0.03 (0.02–0.03)	0.03 (0.02–0.05)	0.02 (0.01–0.03)	0.03 (0.01–0.04)
331 – 365 Follow-up	0.02 (0.01–0.03)	0.03 (0.01–0.04)	0.02 (0.01–0.03)	0.02 (0.01–0.04)

^*among patients with a perioperative fill